Showing results (291-300 of 318) with videos related to

Sort By:
Pageof 32
Plos Pathogens|September 19, 2019
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Plos Pathogens|December 3, 2019
Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2020
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibodyMangaiarkarasi Asokan, Joana Dias, Cuiping Liu, et al.
Immunity|February 26, 2026
HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized miceNicolas M S Galvez, Adam D Nitido, Seo Bin Yoo, et al.
Nature Communications|July 29, 2015
Evaluation of candidate vaccine approaches for MERS-CoVLingshu Wang, Wei Shi, M Gordon Joyce, et al.
Nature Communications|February 21, 2020
Immune checkpoint modulation enhances HIV-1 antibody inductionTodd Bradley, Masayuki Kuraoka, Chen-Hao Yeh, et al.
Scientific Reports|October 26, 2022
Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half lifeBaoshan Zhang, Deepika Gollapudi, Jason Gorman, et al.
Science Translational Medicine|September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challengeBoris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.
Nature Medicine|December 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaquesPeng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.
Cell Reports|August 7, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell SignatureCheng Cheng, Hongying Duan, Kai Xu, et al.
Pageof 32